Magnetar Financial LLC Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

Magnetar Financial LLC raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 19.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 708,732 shares of the medical device company’s stock after acquiring an additional 117,720 shares during the quarter. Cooper Companies accounts for approximately 1.5% of Magnetar Financial LLC’s investment portfolio, making the stock its 15th largest holding. Magnetar Financial LLC’s holdings in Cooper Companies were worth $65,154,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Fulton Bank N.A. raised its holdings in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Torray Investment Partners LLC increased its position in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. increased its position in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Cooper Companies by 15.6% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares during the last quarter. Finally, Greenleaf Trust increased its position in shares of Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on COO shares. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Friday, March 7th. Morgan Stanley reduced their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Finally, Citigroup reduced their price target on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Price Performance

Shares of COO stock opened at $80.12 on Thursday. The firm has a market cap of $16.02 billion, a P/E ratio of 41.09, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a fifty-two week low of $77.05 and a fifty-two week high of $112.38. The business’s 50 day moving average price is $90.45 and its 200-day moving average price is $98.44. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.